Video on Demand

Download Program
Date April 10, 2021 (Saturday) Virtual Conference  
Program Scientific Lectures (tentative rundown)  
1400 - 1405 Opening Speech by President  
  Session 1 - Lymphoid Disorders Symposium  
  Chairperson: Prof. Eric Wai-choi TSE, Dr. Vivien Wai-man MAK and Dr. Rosalina Ka-ling IP  
1405 - 1435 The new era for chemotherapy-free treatments in CLL
Dr. John M Pagel, USA
1440 - 1510 Measurable residual disease measurement for lymphoid neoplasms
Dr. Rock Leung, Hong Kong, QMH
1515 - 1545 Evolving therapies in DLBCL
Prof. Andrew Davies, UK
1545 - 1600 Break (Posters and Exhibits)  
  Session 2 - Presidential Symposium  
  Chairperson: Dr. Man-fai LAW  
1600 - 1640 Practical considerations of CAR-T treatment in Haematological Malignancies
Prof. Ulrich J├Ąger, Austria
1640 - 1650 Q&A  
  Session 3 - Multiple Myeloma Symposium  
  Chairperson: Dr. William Wai-lap CHOI and Dr. Joycelyn Pui-yin SIM  
1655 - 1725 The Changing Landscape: Managing Frontline Multiple Myeloma
Prof. Robert Z. Orlowski, USA
1730 - 1800 Evolving paradigms in the management of Relapsed and Refractory Multiple Myeloma
Prof. Ola Landgren, USA
1800 - 1815 Break (Posters and Exhibits)  
  Session 4 - Young Fellow and Best Abstract Presentations  
  Chairperson: Dr. Man-fai LAW and Dr. Helen Man-hong CHAN  
1815 - 1945 Presentation 1: Impact of Philadelphia Chromosome/BCR-ABL1 fusion gene on the outcomes of B Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era - A retrospective multicenter analysis
Dr Karen Hiu-Ching CHIU, Hong Kong
Presentation 2: Treatment outcome of adult patients with acute lymphoblastic leukemia with HyperCVAD: ten-year experience and the way forward
Dr Jacky Shun-Yin KONG, Hong Kong
Presentation 3: Multiple myeloma in elderly patients - Real world local data
Dr. Jaime Tsui-Yin LEE, Hong Kong
Presentation 4: A retrospective study on the clinical features and outcomes of patients with systemic AL amyloidosis in a single centre in Hong Kong
Dr Wai-Pan LAU, Hong Kong
Presentation 5: Treatment of relapsed/ refractory multiple myeloma with Ixazomib and Daratumumab, the real life experience from a regional hospital
Dr Justin Ka-Shu LI, Hong Kong
Presentation 6: Comparison of clinical outcome following G-CSF alone versus G-CSF and cyclophosphamide as peripheral blood stem cell mobilization in multiple myeloma
Dr. Frankie King-Wai TAM, Hong Kong
Presentation 7: A retrospective review of Monoclonal antibody immobilization of the platelet antigens (MAIPA) to detect autoantibodies in immune thrombocytopenia patients and its clinical significance in local Hong Kong population
Dr. Kelly Ka-Yee WONG, Hong Kong
Presentation 8: Best Abstract Presentation
Haplo-Identical HSCT Outcomes From Queen Mary Hospital HK
Dr. Garret Man-Kit LEUNG, Hong Kong
1945 - 1950 Closing Remarks